Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C1788
http://purl.obolibrary.org/obo/NCIT_C1788
|
|---|---|
| Preferred Name | Aprinocarsen |
| Definitions |
A synthetic phosphorothioate oligodeoxynucleotide. As an antisense molecule, aprinocarsen hybridizes to the 3-untranslated region of the human protein kinase C (PKC-alpha) mRNA, thereby inhibiting PKC-alpha expression and growth of PKC-alpha-dependent tumor cells. (NCI04)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A synthetic phosphorothioate oligodeoxynucleotide. As an antisense molecule, aprinocarsen hybridizes to the 3-untranslated region of the human protein kinase C (PKC-alpha) mRNA, thereby inhibiting PKC-alpha expression and growth of PKC-alpha-dependent tumor cells. (NCI04) |
|---|---|
| prefLabel | Aprinocarsen
|
| label | Aprinocarsen
|
| PDQ_Closed_Trial_Search_ID | 42953
|
| code | C1788
|
| prefixIRI | NCIT:C1788
|
| in_subset | |
| Preferred_Name | Aprinocarsen
|
| FDA_UNII_Code | FMT95051CQ
|
| Contributing_Source | FDA
|
| Maps_To |
Aprinocarsen
PKC-alpha Antisense Oligodeoxynucleotide ISIS 3521
|
| CAS_Registry | 151879-73-1
|
| NSC Number | 719337
|
| NCI_Drug_Dictionary_ID | 42953
|
| Legacy Concept Name | ISIS_3521
|
| type | |
| ALT_DEFINITION | A substance that is being studied in the treatment of cancer.
|
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 42953
|
| Semantic_Type |
Pharmacologic Substance
Nucleic Acid, Nucleoside, or Nucleotide
|
| UMLS_CUI | C0666551
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |